Robinson, Reeder M.
Reyes, Leticia
Duncan, Ravyn M.
Bian, Haiyan
Reitz, Allen B.
Manevich, Yefim
McClure, Jesse J.
Champion, Matthew M.
Chou, C. James
Sharik, Meahgen E.
Chesi, Marta http://orcid.org/0000-0002-4024-8225
Bergsagel, P. Leif http://orcid.org/0000-0003-1523-7388
Dolloff, Nathan G.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (P20GM103542)
American Cancer Society (RSG-14-156-01-CDD)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (1R41CA213488-01)
U.S. Department of Health & Human Services | National Institutes of Health (UL1 RR029882)
Article History
Received: 25 May 2018
Revised: 24 July 2018
Accepted: 22 August 2018
First Online: 12 October 2018
Compliance with ethical standards
:
: RMR and NGD are inventors on patents. NGD has an ownership interest in Leukogene Therapeutics, Inc. The other authors declare that they have no conflict of interest.